Stockholm, January 7, 2020 – Swedish digital health company Coala Life today announced a research and development partnership with Asahi Kasei Corporation in Japan. The collaboration includes a development program and feasibility research targeting Heart Failure (HF) patients in Japan. Nearly one million patients are suffering from Heart Failure (HF) in Japan. The country also has the …
IRVINE, December 19, 2019 – The High Desert Heart Institute in California, part of nationwide Prime Healthcare group, has signed a partnership with Coala Life to utilize the Coala Heart Monitor on a broad scale. The agreement constitutes the first major healthcare provider contract for Coala Life in the US following recent market launch. Clinical …
STOCKHOLM, DECEMBER 11, 2019 – In order to continue our strategic drive to grow the health care business and align our sales and marketing efforts the role Chief Commercial Officer has been created. With the recent FDA clearance for Coala in the US and the subsequent launch in the US, Germany and soon the Netherlands, …
STOCKHOLM, 22 November, 2019 – Införandet av Coala Heart Monitor Pro leder till effektivare processer, lägre kostnader, kortare vårdköer och ökad patientnöjdhet. Det visar en klinisk utvärdering som genomförts vid Aleris Hjärtmottagning Sabbatsberg. Aleris Hjärtmottagning på Sabbatsbergs sjukhus har under 2019 använt Coala Heart Monitor Pro för att utföra digitala arytmiutredningar på 100 patienter …
STOCKHOLM, November 22, 2019 – Implementation of the Coala Heart Monitor leads to higher clinical efficiency, lower costs, shorter waiting lists and higher patient satisfaction. That is the results of a clinical evaluation performed at the Cardiology Clinic at Aleris Sabbatsberg. In 2019, Aleris Cardiology Clinic at Sabbatsberg hospital used Coala Heart Monitor to …
Irvine, CA, US – October 2nd, 2019 – Swedish digital health company Coala Life today announced its market launch in the US in collaboration with leading US cardiologists and healthcare providers. The launch follows recent FDA clearance for the Coala Heart Monitor and subsequent A-series funding. The Coala Heart Monitor (“Coala”) is a real-time …
STOCKHOLM Augusti 30, 2019 – Coala Life expanderar och lanserar på den Nederländska marknaden genom ett samarbete med Luscii healthtech. Nederländerna, med sjukvårdskostnader som närmar sig 100 miljarder dollar, är ett stort och inflytelserikt nav i den europeiska medicintekniska industrin som återkommande rankas som en av de fem största marknaderna för medicintekniska produkter. Det …
STOCKHOLM August 30, 2019 – Today Coala Life announces entry into the Dutch market in partnership with Luscii. The Netherlands, with healthcare expenditures approaching $100 Bn, is a major and influential hub in the European medical device industry frequently ranked in the top 5 global medical device markets. The Swedish medtech company Coala Life, …
STOCKHOLM 2019-06-27. Coala Life har idag rest ytterligare drygt 11 miljoner kronor i expansionskapital för att accelerera kommersialiseringen och etablera bolaget på den amerikanska marknaden. Rundan har huvudsakligen tecknats av Blue, ett svenskt investmentbolag, samt av ledande befattningshavare i bolaget. Det svenska medicinteknikföretaget Coala Life, pionjären inom digital hjärtdiagnostik och individcentrerade medicinska innovationer, har idag …
